Other
LGTX-101
A therapeutic T-cell-engager antibody candidate.
Other
labgeniustx.com/pipeline- Milestones0
- Sources1
- Operators—
- Components—
Other · No licensed photo on file
A therapeutic T-cell-engager antibody candidate.
Timeline
No milestones recorded for LGTX-101 yet. The timeline fills in as unveilings, tests, contracts and deliveries are sourced.
Sources1
- 1.
LabGenius Therapeutics · Supports: System
“Through the tight integration of high-throughput functional cell-based experimentation with machine learning (ML), LabGenius’ proprietary lead optimisation platform (*EVA™*) generated a highly selective and potent trivalent VHH-based Nectin-4 x CD3 T-cell engager (TCE), LGTX-101”
Each fact on this page is attached to the sources that support it. Archived copies are linked when we keep one.